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Inhibition of Axonal Growth by Brefeldin A in Hippocampal Neurons
in Culture
Mark Jareb and Gary Banker
Department of Neuroscience, University of Virginia School of Medicine, Charlottesville, Virginia 22908
The outgrowth of neuronal processes involves a great increase
in the surface area of the cell. The supply of membrane material
necessarily must be coordinated with the demands for neurite
growth. The selective growth of only one or two neurites at any
given time during the development of polarity raises the possi-
bility that the production of materials by the soma is limiting for
growth (Dotti and Banker, 1987; Dotti et al., 1988; Goslin and
Banker, 1990). To examine the role of the availability of mem-
brane components during the development of polarity and
axonal elongation, we treated neurons with brefeldin A, an
antibiotic that disrupts the trafficking of vesicles from the Golgi
complex to the plasma membrane. Treatment with brefeldin A
(1 mg/ml) inhibited axonal growth within 0.5 hr; in unpolarized
cells it prevented the formation of an axon. These results
indicate that the availability of membrane components of Golgi-
derived vesicles is required for axonal growth and hence the
development of polarity. Inhibitors of protein and RNA synthesis
also blocked axonal growth and the development of polarity,
but over a much slower time course. This suggests that the full
complement of proteins and mRNAs required for the initial
development of polarity is present for several hours before
polarity is actually established.
Key words: polarity; neurite outgrowth; hippocampal neu-
rons; brefeldin A; Golgi complex; axonal transport
Axonal growth involves a great increase in volume and surface
area. Hence, growth cone advance and the transport of cytoskel-
etal and membrane constituents must be linked. The selective
transport of these constituents may underlie the selective out-
growth of neurites observed during synapse formation or the
development of neuronal polarity (Dotti et al., 1988; O’Rourke
and Fraser, 1990). Indeed, differential transport of vesicular
elements has been observed directly in different branches
of the neurites of cultured Aplysia neurons (Goldberg and
Schacher, 1987).
Few experiments have examined the link between axonal
growth and the supply of materials produced in the cell body. One
such experiment used optical tweezers to trap materials trans-
ported along the neurites of chick sensory neurons (Martenson et
al., 1993). This led, after a delay of minutes, to collapse of
the growth cone and cessation of elongation. The latency be-
tween blockade of vesicle transport and inhibition of growth
suggested that outgrowth depends, on a moment-to-moment ba-
sis, on the delivery of some element moving by rapid axonal
transport.
Disruption of axonal transport may simultaneously interrupt
the supply of membrane constituents, cytoskeletal elements, and
regulatory components governing their assembly. To investigate
more specifically the importance of membrane elements in neu-
rite growth, we have examined the effects of brefeldin A (BFA) on
the development of cultured hippocampal neurons. BFA acts by
inhibiting a Golgi-associated guanine nucleotide exchange pro-
tein acting on ADP-ribosylation factor (ARF) (Donaldson et al.,
1992; Helms and Rothman, 1992). Because ARF1 plays a central
role in controlling vesicular traffic from the endoplasmic reticu-
lum (ER) to the Golgi complex and between successive Golgi
compartments, BFA treatment results in the redistribution of coat
proteins from Golgi membranes to cytosol, the inhibition of
vesicular traffic from the Golgi complex, and the collapse of the
Golgi complex into the ER (Dascher and Balch, 1994; Elazar et
al., 1994; Zhang et al., 1994). BFA also affects the recycling of
endocytosed proteins also via ARF family members, but unlike
the biosynthetic pathway, membrane recycling continues, al-
though at a slower rate (Damke et al., 1991; Lippincott-Schwartz
et al., 1991; Barroso and Sztul, 1994; Schonhorn and Wessling-
Resnick, 1994; Stoorvogel et al., 1996). In cultured hippocampal
neurons, the cell surface expression of proteins via defective
herpesvirus vectors and the appearance of Golgi-derived vesicles
labeled with fluorescent lipids are blocked by BFA treatment
(Craig et al., 1995).
In this report we examine the effects of BFA on neurite out-
growth and the development of polarity. We confirm that BFA
rapidly and reversibly disrupts the Golgi complex and prevents
the cell surface expression of exogenous membrane proteins in
cultured hippocampal neurons. We then show that neurons that
have not yet formed axons fail to do so in the presence of BFA.
In neurons that have formed axons at the time of exposure to
BFA, axonal elongation ceased within 30 min. Inhibitors of pro-
tein synthesis also block the formation and elongation of axons,
but their effects on neurite growth are apparent only after several
hours.
MATERIALS AND METHODS
Materials. Brefeldin A (Epicentre Technologies, Madison, WI) was
stored at 220°C as a stock solution of 5 mg/ml in ethanol. BFA was added
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directly to the culture medium at a final concentration of 3.57 mM (1
mg/ml) in all experiments, unless otherwise noted. Cycloheximide (71
mM; 7.1 mM aqueous stock solution), emetine (40 mM; 1.6 mM aqueous
stock solution), or puromycin (50 mM; 2 mM aqueous stock solution) was
added to the medium to inhibit protein synthesis. Actinomycin D (8 mM;
1.6 mM aqueous stock solution) was added to the medium to inhibit the
synthesis of RNA. The cultures were rinsed twice in MEM, and then
glial-conditioned medium was added to the dish to examine the effects of
drug removal.
Cell culture. Methods for preparing hippocampal cell cultures have
been described previously (Goslin and Banker, 1992). In brief, cell
suspensions were prepared by trypsin treatment of hippocampi (dissected
from the brains of 18 d rat fetuses) and trituration using a fire-polished
Pasteur pipette. Dissociated cells were plated on poly-L-lysine-treated
glass coverslips in MEM. After allowing 3–4 hr for cells to adhere, we
transferred the coverslips to a new dish, such that a space of ;1 mm
separated the coverslip from a monolayer of glia. The medium in this
dish was glial-conditioned MEM containing the N2 supplements of
Bottenstein and Sato (1979), together with sodium pyruvate and ovalbu-
min (0.1%).
For experiments involving video microscopy of individual neurons,
coverslips were placed in sealed chambers designed for time-lapse mi-
croscopy or in special culture dishes prepared as described by Goslin and
Banker (1990).
Visualization of the Golg i apparatus. One-day-old neurons were fixed in
cold MeOH, and the Golgi complex was visualized with an antibody to
the Golgi protein mannosidase II (generous gift of Dr. Kelly Moremen,
University of Georgia, Athens, GA, and Dr. Marilyn Farquahr, Univer-
sity of California, San Diego, San Diego, CA). The rabbit polyclonal
antibody was incubated at a dilution of 1:1000, followed by incubations in
biotinylated goat anti-rabbit IgG (1:800; Vector Laboratories, Burlin-
game, CA) and then in FITC-streptavidin (1:800; Vector).
The Golgi complex was also visualized by staining living cells with
N-(4,4-difluoro-5,7-dimethyl-bora-3a,4a-diaza-s-indacene-3-pentanoyl)
sphingosine (DMB-ceramide). A complex of DMB-ceramide with defat-
ted BSA was prepared by adding 100 ml of a 500 mM stock of DMB-
ceramide to 10 ml of MEM containing defatted BSA (0.34 mg/ml), as
described by Lipsky and Pagano (1985). This solution was then dialyzed
against 500 ml of MEM overnight at 4°C, resulting in a final concentra-
tion of ;5 mM for both DMB-ceramide and the defatted BSA. Cultures
were incubated with the 5 mM DMB-ceramide and defatted BSA complex
in MEM for 15 min at 37°C. After incubation, the MEM was replaced
with glial-conditioned medium, and cells were examined by fluorescence
microscopy using a planapo 633 objective.
Expression of exogenous proteins. To test the actions of BFA on the
transport of integral membrane proteins to the cell surface in cultured
neurons, we expressed exogenous proteins using replication-defective
adenovirus. Adenovirus expressing low density lipoprotein receptor
(LDLR) (generous gift of Dr. Robert Gerard, University of Texas,
Southwestern Medical Center, Dallas, TX; Herz and Gerard, 1993) was
added to cultures 18 hr after plating, and BFA was added 4 hr later. Cell
surface expression from adenovirus vectors is first detectable 8 hr after
infection (M. Jareb and G. Banker, unpublished observations). LDLR
expression in control and BFA-treated cultures was visualized with the
monoclonal antibody C7 (Amersham, Arlington Heights, IL) 12 hr after
BFA treatment (16 hr after infection). To examine cell surface staining,
we incubated living neurons with primary antibody for 5 min at 37°C and
then fixed the neurons in 4% paraformaldehyde and 4% sucrose in PBS.
Other cultures were fixed and permeabilized before staining to reveal
both intracellular and surface labeling.
Effects of inhibitors on development of polarity. The effect of inhibitors
on the morphological development of cultured hippocampal neurons was
examined by treating cultures with a drug during the period when most
neurons initially form their axons. Cultures were treated with BFA,
cycloheximide (CHX), actinomycin D (ACT D), or vehicle 18 hr after
plating and then fixed in 2.5% glutaraldehyde 1–12 hr later. Randomly
chosen fields were examined, and the proportion of cells that had devel-
oped axons was determined. A cell was considered to have an axon if the
length of one process was at least twice as long as any other process and
was more than twice the diameter of the cell body (Deitch and Banker,
1993). Cells with multiple axons were not counted. At least 100 cells from
each of two or three coverslips were examined. Repeated-measures
ANOVA was used to compare mean changes in the percentage of
neurons with axons after drug treatment. When appropriate, post hoc
comparisons between control and drug-treated cultures were made using
Student’s t tests.
Effects of inhibitors on neurite elongation. The effect of inhibitors on
neurite elongation was examined by following the growth of individual
cells, beginning ;24 hr after plating. Cells at stage 3 of development
were chosen, and their positions were marked on the coverslip with a
diamond-tipped object marker. Observations were made at intervals of
0.5–3 hr, beginning 2 hr before drug addition and continuing for up to 12
hr. Between observations, the cultures were returned to the incubator.
During each experiment, 12 randomly chosen stage 3 cells were followed
from both drug-treated and vehicle-treated cultures. Process length was
measured using Image-1 image analysis software (Universal Imaging
Corporation, West Chester, PA). Repeated-measures ANOVA was used
to compare mean changes in the relative length of axons or minor
processes after drug treatment. When appropriate, post hoc comparisons
between control and drug-treated cultures were made using Student’s t
tests.
RESULTS
Brefeldin A disrupts the Golgi complex in hippocampal
neurons and prevents the cell surface expression of
membrane proteins
We examined the effects of BFA on the organization of the Golgi
complex in cultured hippocampal neurons, visualizing the Golgi
complex with a rabbit polyclonal antibody to the Golgi resident
protein mannosidase II. In all control neurons (Fig. 1), the Golgi
complex formed a discrete spot, which was usually associated with
an indentation in the nucleus that faces the cytoplasm of the
soma, as described previously (Dotti and Banker, 1991; Deitch
and Banker, 1993). Treatment with BFA (3.57 mM) rapidly and
reversibly disrupted the Golgi complex. Within 15 min, in every
BFA-treated neuron, the Golgi complex became dispersed
throughout the cytoplasm of the cell body (Fig. 1). Thirty minutes
after BFA was removed, the Golgi complex in most neurons had
assumed its normal appearance and localization (Fig. 1). Similar
Figure 1. The effects of brefeldin A on the organization of the Golgi
complex in cultured hippocampal neurons. The Golgi complex was visu-
alized with a polyclonal antibody against the Golgi resident protein
mannosidase II. Fluorescent micrographs were enlarged to show somata
(D–F ). In control neurons (A, D), the nucleus typically lies at one pole of
the cell, and the Golgi complex is present as a single discrete spot near the
edge of the nucleus that faces the cytoplasm. After exposure to BFA (3.57
mM) for 15 min (B, E), mannosidase II immunoreactivity was diffusely
distributed throughout the cytoplasm. Within 30 min after removal of
BFA (C, F ), the Golgi complex had nearly regained its normal position
and appearance. Scale bars, 10 mm.
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results were obtained when DMB-ceramide, a fluorescent lipid
analog, was used to visualize the Golgi complex in living cells
(data not shown) (Pagano et al., 1991).
We tested the ability of BFA treatment to block protein trans-
port through the Golgi complex in rat hippocampal neurons by
expressing an exogenous membrane protein, the LDLR, using an
adenovirus vector. BFA was added to cultures 4 hr after infection,
and LDLR expression was examined 12 hr later. In control
neurons LDLR was expressed on the surface of minor processes,
cell bodies, and proximal portions of the axon (Fig. 2). Live
staining of sister cultures treated with BFA and infected with
LDLR adenovirus revealed no detectable surface labeling (data
not shown). To confirm that BFA-treated cultures were infected,
we detected LDLR expression in permeabilized neurons, in
which it exhibited a tubular appearance consistent with an intra-
cellular localization (Fig. 2). This is consistent with previous work
that shows that cell surface expression of the T-cell marker CD8
introduced into rat hippocampal neurons via replication-defective
herpesviruses is blocked by BFA (Craig et al., 1995).
Brefeldin A inhibits the development of polarity
During the first 48 hr after plating, the vast majority of hippocam-
pal neurons undergo the transformation from a round, unpolar-
ized cell to a polarized neuron with a single axon. Most cells
develop axons and acquire a polarity between 18 and 36 hr after
plating. To determine whether exposure to BFA influences the
development of polarity, we examined the effects of adding BFA
(3.57 mM) to hippocampal cultures 18 hr after plating. Figure 3
illustrates representative fields from a control culture 24 hr after
plating and from a culture treated with BFA 18 hr after plating
and examined 6 hr later. In the untreated culture (Fig. 3A),
approximately half of the neurons have formed a single axon in
addition to several minor processes (stage 3 of Dotti et al., 1988).
The other neurons had several minor processes but had not yet
developed axons (stage 2 of development). In the culture treated
with BFA (Fig. 3B), most of the neurons had not formed axons.
We quantified the effects of BFA on the development of mor-
phological polarity by fixing cultures at varying times after the
addition of BFA and counting the number of neurons that had
formed axons (Fig. 4). In control cultures, the percentage of
neurons with axons increased at an approximately linear rate
(;3% of cells formed axons each hour), with ;50% of the cells
having formed axons by 30 hr after plating. In cultures treated
with BFA, the normal increase in the percentage of neurons with
axons was significantly reduced within 1 hr ( p , 0.05). Six hours
after adding BFA, the percentage of neurons with axons had
actually fallen slightly. After removal of BFA, cells resumed
forming axons at the rate observed in control cultures. As shown
in Figure 4B, inhibition of the development of polarity by BFA
was dose-dependent. Axonal development was significantly inhib-
ited at 0.71 mM BFA and was completely blocked at a concentra-
tion of 3.57 mM. No significant inhibition of axonal development
was observed at a concentration of 0.14 mM BFA.
Although it is not surprising that a drug that blocks secretion
and disrupts pathways through the Golgi complex might interfere
with the formation of the axon, we were struck by the rapidity of
its action on axonal development. To provide a frame of reference
for this result, we compared the time course of action of BFA with
that of cycloheximide, an inhibitor of protein synthesis, and
actinomycin D, an RNA synthesis inhibitor. Obviously, blockade
of protein synthesis generally (either directly or by depletion of
mRNAs) or of the Golgi-mediated synthesis of membrane con-
stituents is ultimately likely to block neurite outgrowth and there-
fore the development of neuronal polarity. Hence, these experi-
ments were intended to compare the time courses of the effects of
these drugs on the development of polarity.
Figure 5 compares the effects of BFA (3.57 mM), cycloheximide
(CHX; 71 mM), and actinomycin D (ACT D; 8 mM). BFA inhib-
ited the development of polarity much more rapidly than either
CHX or ACT D. Compared with control cultures, the change in
the percentage of BFA-treated neurons with axons was signifi-
cantly reduced within 1 hr after drug addition ( p , 0.05). In
Figure 2. The effects of brefeldin A on the cell surface expression of
proteins in cultured hippocampal neurons by replication-defective adeno-
virus. LDLR was expressed in 1-d-old neurons using replication-defective
adenovirus. The distribution of LDLR was visualized by immunofluores-
cence. The fluorescence micrographs illustrate a representative cell from
a control culture 16 hr after infection (A, C) and from a culture exposed
to BFA (3.57 mM) 4 hr after infection and fixed 12 hr later (B, D). In the
control cultures, cell surface labeling was observed on minor processes,
the cell body, and the proximal axon. In BFA-treated cultures, labeling
was confined primarily to the cell body and exhibited a tubular appear-
ance. When BFA-treated cultures were exposed to antibody before fixa-
tion (to prevent intracellular labeling), no staining was observed. Scale
bar, 20 mm.
Figure 3. The effects of brefeldin A on the morphological development
of cultured hippocampal neurons. The phase contrast micrographs illus-
trate representative fields from a control culture 24 hr after plating (A)
and from a culture exposed to BFA (3.57 mM) 18 hr after plating and
photographed 6 hr later (B). In the control culture, half of the neurons
have become polarized (asterisks), i.e., they had formed a single, long
axon as well as several, short, minor processes. The other neurons had
minor processes but had not yet developed axons (arrows). In cultures
treated with BFA, unpolarized cells predominate. Scale bar, 20 mm.
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contrast, the change in the percentage of polarized neurons in
cultures treated with CHX (71 mM) was significantly reduced in
comparison with controls only after 6 hr of treatment ( p , 0.05).
This concentration of CHX inhibits protein synthesis in cultured
hippocampal neurons by .90% (Kleiman et al., 1993). Similar
results were observed with emetine (18 mM) and puromycin (46
mM), protein synthesis inhibitors with different modes of action
than CHX. Inhibition of the development of polarity by ACT D
(8 mM) followed an even longer time course. These data show that
BFA has a much more rapid effect on the development of polarity
than does the inhibition of either RNA or protein synthesis.
The effects of BFA on axonal elongation
To determine whether BFA also inhibits the elongation of axons
that have formed previously, we followed the growth of individual
cells in BFA by video microscopy for up to 12 hr. Figure 6
illustrates a typical example. Before the addition of BFA, the
axon of this cell was elongating at 5 mm/hr. Within 1 hr of
treatment, axonal elongation had ceased completely. After 3 hr, a
slight retraction of the axon had occurred, and this became more
pronounced over time. Although elongation ceased, the morphol-
ogy and motility of the axonal growth cone appeared normal for
6 hr or more. By comparison with the axon, minor processes were
relatively unaffected. Some retraction was observed at 3 and 6 hr,
Figure 4. Brefeldin A inhibits the development of morphological polarity
by cultured hippocampal neurons. A, Cultures were treated with BFA
(3.57 mM) at 18 hr after plating and examined at varying times later. In
control cultures (open circles), ;23% of the cells had become polarized 18
hr after plating, and the proportion of cells that developed axons in-
creased at an approximately linear rate during the next 12 hr. In the
presence of BFA ( filled circles), there was no increase in the number of
cells that developed axons. By 3 hr there was a slight but significant
decrease in the proportion of polarized cells. If BFA was removed after 6
hr of exposure, cells resumed axonal development at approximately the
same rate observed in control cultures. Time points for BFA-treated and
control cultures represent means from four experiments. Time points
from cultures in which BFA was removed represent means from two
experiments. In each experiment at each time point, two or three cover-
slips were fixed, and the proportion of cells with axons was determined,
based on counts of 200–300 cells. B, The effects of brefeldin A on axonal
development were dose-dependent. Cultures were treated with BFA at
concentrations of 0.14 mM ( filled squares), 0.71 mM ( filled triangles), or
3.57 mM ( filled circles). At the highest concentration tested (3.57 mM),
axonal development was completely inhibited. Lower concentrations (as
low as 0.71 mM) significantly reduced the rate of axonal development.
Time points represent means from two experiments. In each experiment
at each time point, two or three coverslips were fixed, and the proportion
of cells with axons was determined, based on counts of 200–300 cells.
Figure 5. Brefeldin A inhibits the development of polarity more rapidly
than do inhibitors of protein or RNA synthesis. Cultures were treated
with BFA (3.57 mM; filled circles), cycloheximide (71 mM; filled triangles), or
actinomycin D (8 mM; filled squares) at 18 hr after plating and examined
at varying times later. In control cultures (open circles), the proportion of
neurons that developed axons increased at an approximately constant
rate. All three drugs inhibited the development of a polarized morphol-
ogy, but the effects of BFA were much more rapid. After addition of BFA,
a reduction in the expected increase in the number of polarized cells was
evident by 1 hr ( p , 0.05, compared with control cultures). A statistically
significant reduction in the proportion of neurons that had developed
axons was first apparent 6 hr after addition of cycloheximide and 9 hr
after addition of actinomycin D. Time points represent means from three
experiments. In each experiment at each time point, two or three cover-
slips were fixed, and the proportion of cells with axons was determined,
based on counts of 200–300 cells.
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but by 12 hr these processes had re-extended to their former
length despite the continued presence of the drug.
To assess further the effects of BFA on growth cone morphol-
ogy, we followed individual cells by time-lapse recording for up to
12 hr (Fig. 7). After .6 hr of BFA treatment, 86% of the neurons
still exhibited prominent growth cones. Surprisingly, although
BFA-treated neurons showed a marked net retraction of the axon
over time, axons still exhibited occasional spurts of growth, and
their growth cones remained motile.
The effects of CHX on axonal elongation were quite different
(Fig. 8). In the example shown, the axon continued to elongate at
its previous rate for .3 hr after addition of CHX. Subsequently,
elongation stopped, and the axon retracted somewhat, but this
was not nearly as pronounced as was observed in BFA-treated
neurons. Coincident with inhibition of axonal growth, the axon
became noticeably thinner, and its growth cone disappeared.
Minor processes of CHX-treated neurons appeared unaffected.
Figure 9 summarizes our observations of the effects of BFA and
cycloheximide on the rate of axonal elongation. When BFA was
added ;24 hr after plating, the average net growth of axons was
significantly reduced within 30 min compared with controls. By 1
hr, axonal elongation was completely inhibited. Net retraction of
axons became pronounced by 4 hr after addition of BFA, and by
12 hr axons had retracted an average of 50 mm. In contrast, the
average net growth of CHX-treated axons was significantly inhib-
ited only after 6 hr, and the average retraction of axons was much
less pronounced than that seen in BFA-treated cultures. Neither
drug systematically affected the growth or retraction of minor
processes. Minor processes in control cultures exhibited spurts of
elongation and retraction of up to 20 mm, but the average net
growth of minor processes over the 12 hr examined was ,1 mm.
Minor processes in drug-treated cultures exhibited similar, dy-
namic elongation and retraction; neither BFA nor CHX caused a
marked retraction of minor processes.
The effects of BFA on neuronal polarity
Previous work has shown that transection of the axon in stage 3
cells can alter the polarity of the neuron (Goslin and Banker,
1990). If the axon is transected near the cell body, at approxi-
mately the same length as the other processes of the cell, a new
axon may form from one of the other minor processes of the cell.
In contrast, if the axon is transected at some distance from the
cell body, so that the axonal stump remains significantly longer
than the other processes of the cell, the transected axon regen-
erates, maintaining the initial polarity of the cell. We were inter-
ested in determining whether axonal retraction induced by BFA
could similarly alter the polarity of neurons. We followed indi-
vidual cells during exposure to BFA to determine the degree of
axonal retraction; then we removed BFA and examined the sub-
sequent response of the cell for up to 48 hr. Figure 10 illustrates
a neuron whose axon retracted back to the length of a minor
process after 6 hr of exposure to BFA. When BFA was removed
and the cell was examined 12 hr later, it had again formed an
axon. The new axon arose not from the original axon but from
one of the minor processes. In 4 of 22 cells, the axon retracted so
markedly that the length of the axon was within 15 mm of the
longest minor process. In three of the four cases, the polarity of
the cell was altered after removal of BFA. In contrast, in all 18
cases in which the axon retracted, but still remained at least 15
mm longer than the longest minor process, the axon retained its
identity after removal of BFA. These data suggest that neurons
respond to the BFA-induced changes in axonal length in much
the same way as do cells whose axons have been transected.
DISCUSSION
The elongation of neurites involves a large expansion in surface
area and volume. The supply of membranous and cytoskeletal
elements must meet the demands of growth. Furthermore, the
neurites of cultured neurons exhibit selective growth, suggesting
that the materials required for growth are limited in quantity. We
compared the roles that different components synthesized in the
cell body play during axonal growth and the development of
neuronal polarity. Brefeldin A, which blocks traffic through the
Golgi complex, rapidly inhibited the development of polarity and
selectively inhibited axonal elongation in polarized neurons. In-
Figure 6. The effects of brefeldin A on neurite elongation. The culture was treated with BFA (3.57 mM) ;24 hr after plating. This series of phase contrast
micrographs illustrates a cell just before BFA treatment (A) and 1 hr (B), 3 hr (C), 6 hr (D), and 12 hr (E) after addition of BFA. Axonal elongation,
which was evident before the addition of BFA, was completely inhibited within the first hour after treatment. After 3 hr, retraction of the axon was
evident, although the axonal growth cone retained its normal appearance for .6 hr after addition of BFA. By 12 hr, the axon had retracted .60 mm,
and the axonal growth cone had lost any lamellipodia or filopodia. The minor processes seemed primarily unaffected by treatment with BFA. Scale bar,
20 mm.
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hibition of protein or RNA synthesis also inhibited axonal out-
growth and the development of polarity, but over a much longer
time course. These data suggest that the continuous availability of
Golgi-derived components is required for axonal growth.
Mechanism of action of BFA
The mechanism of action of BFA is critical to the interpretation
of the results presented here. BFA acts by inhibiting the GDP–
GTP exchange on ARF1, a protein necessary for the vesicular
traffic from the ER to the Golgi complex and between successive
Golgi stacks. One caveat concerning the actions of BFA is that
they may differ somewhat among different cell types (Ktistakis et
al., 1995, 1996). Rat hippocampal neurons seem to respond to
BFA similarly to most other cell types, including other neurons.
We showed that the Golgi complex is disrupted by BFA treatment
and membrane proteins expressed via adenovirus or herpesvirus
are unable to reach the cell surface (Craig et al., 1995). In
contrast, Cid-Arregui et al. (1995) found that the cell surface
expression of membrane proteins introduced into rat hippocam-
pal neurons with the Semliki Forest virus (SFV) was not blocked
by BFA. One possible explanation for this discrepancy is that
membrane proteins encoded by SFV may use an ARF-
independent mechanism to reach the cell surface. Alternatively,
because of rapid expression of proteins via SFV vectors, some
surface expression may have occurred before BFA treatment.
In addition to blocking traffic from the Golgi complex in most
cells, BFA causes tubulation of the endosomal system and per-
turbs the recycling of endocytosed proteins (Damke et al., 1991;
Schonhorn and Wessling-Resnick, 1994; Stoorvogel et al., 1996).
However, unlike the action of BFA on the biosynthetic pathway,
membrane traffic through recycling compartments can continue,
although at a slower rate (Damke et al., 1991; Lippincott-
Schwartz et al., 1991; Barroso and Sztul, 1994; Schonhorn and
Wessling-Resnick, 1994). Because BFA causes tubulation of en-
dosomes in hippocampal neurons (Mundigl et al., 1993), protein
recycling likely is also slowed by BFA. Because protein recycling
still continues, the effects of BFA caused by perturbation of
endocytic processes would be much less severe compared with the
complete inhibition of traffic from the Golgi complex.
In Madin–Darby canine kidney cells, a polarized epithelial cell
line, BFA also disrupts membrane recycling. A number of apical
and basolateral proteins are recycled indiscriminately to both
domains in the presence of BFA (Hunziker et al., 1991; Prydz et
al., 1992; Wan et al., 1992; Matter et al., 1993). De Hoop et al.
(1995) suggested that a similar missorting of endocytosed pro-
teins may occur in hippocampal neurons. Indiscriminate recycling
of axonal membrane proteins could play a role in the effects of
BFA on axonal elongation, although this would likely be second-
ary to its blockade of Golgi-derived traffic.
Inhibition of axonal growth during BFA treatment
The most dramatic effect of BFA treatment was the rapid inhibi-
tion of axonal growth. In polarized neurons, within 30 min of
treatment, axonal elongation ceased, and shortly thereafter the
axon started to retract. In unpolarized cells, BFA prevented the
initiation of axonal outgrowth that marks the initial establishment
of polarity. This time course of inhibition is consistent with the
fastest rates of vesicle traffic observed from the ER to the cell
surface (Wieland et al., 1987; Young et al., 1992; Andreose et al.,
1996), suggesting that axonal elongation is blocked concomitantly
with the depletion of Golgi-derived vesicles. Studies that blocked
organelle transport using optical tweezers further support this
idea (Martenson et al., 1993). The time course of inhibition of
axonal growth correlated with the estimated time of fast axonal
transport from the site of blockade to the growth cone. On the
other hand, work showing that axonal membrane flow in chick
DRG neurons is considerably greater than their elongation rate
suggests a considerable pool of membrane is available for growth
(Dai and Sheetz, 1995).
What Golgi-derived materials are crucial for the maintenance
and regulation of axonal growth and the development of polarity?
One possibility is that the continuous availability of one or more
membrane proteins is required to sustain axonal growth. The
differences between the inhibitory effects of BFA and CHX argue
Figure 7. Axonal growth spurts persist for hours in brefeldin A. This set
of phase contrast micrographs illustrates a cell just before BFA treatment
(A) and at several time points between 6 and 11 hr after the addition of
BFA ( B–E). At 6 hr after BFA treatment, the axon had retracted mark-
edly (B). Twenty minutes later a growth spurt in excess of 10 mm was
evident (C). Fifteen minutes later, axonal retraction was observed (D).
Several hours later, a motile axonal growth cone still persisted (E). The
individual frames shown were taken from a time-lapse video recording in
which images were collected every 8 sec. Scale bar, 20 mm.
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against this hypothesis. If both BFA and CHX act by depleting
the availability of particular membrane proteins, then the differ-
ence in the time course of their effects should reflect the point at
which these drugs block protein traffic along the exocytic pathway.
The transit time from the ER to the cell surface for typical
membrane proteins is in the range of 1–2 hr (Lundstrom et al.,
1993; Thorens et al., 1993; Akasaki et al., 1995; Pimental et al.,
1996). Only 1–2 min would be required for vesicles to travel to the
growth cone by rapid transport. Yet, growth of CHX-treated
axons was not affected until 3–4.5 hr after drug addition. Some
multisubunit receptors do reside intracellularly for longer than 3
hr (Vitetta and Uhr, 1975; Devreotes et al., 1977). However, in
other types of neurons, inhibition of axonal growth by protein
synthesis inhibitors requires an even longer time (Daniels, 1973;
Estridge and Bunge, 1978; Lein and Higgins, 1991). Furthermore,
differences in the morphology of BFA- and CHX-treated neurons
suggest their mechanisms of action may be different. The inhibi-
tion of axonal growth by CHX treatment coincided with loss of
the growth cone and a thinning of the axon, whereas in BFA-
treated axons the growth cone remained motile for hours after
net elongation had stopped.
An alternative explanation of the effects of BFA treatment on
axonal elongation is that the lipid components of the Golgi-
derived vesicles are required for axonal growth. Logically, avail-
ability of bulk lipids should be required for growth, because the
concomitant increases in surface area and volume of a growing
axon would require the net addition of membranous material. Dai
and Sheetz (1995) have proposed a model in which membrane
tension could act to regulate neurite growth. In chick DRG
neurons, they observed that the axonal membrane flowed toward
the cell body, consistent with a relatively low membrane tension
at the growth cone and a relatively high membrane tension at the
cell body. In cases in which the membrane tension at the growth
cone increases, such as with BFA treatment (Dai and Sheetz,
1995), elongation of a neurite necessarily requires a stronger
motile force. Increased membrane tension, caused by BFA block-
ing the insertion of new membrane, may be the mechanism by
which axonal elongation ceases; if the tension at the growth cone
reached a high enough level, then filopodial extension would tend
to be inhibited, and retraction could be favored.
Perturbations in the levels of a single lipid species in the plasma
membrane can also have significant effects on neurite outgrowth.
For example, inhibitors of sphingolipid synthesis were shown to
inhibit axonal or dendritic growth in a number of different neu-
rons (Harel and Futerman, 1993; Furuya et al., 1995; Boldin and
Futerman, 1997; Dechaves et al., 1997). However, many of these
effects require many hours or days in contrast to the rapid effects
of BFA.
The development and maintenance of polarity
In hippocampal cultures, the transition a neuron undergoes from
an apparently unpolarized cell with several identical neurites to a
cell with a single axon that has acquired its defining morpholog-
ical and molecular properties occurs quite abruptly, in as little as
1 hr (Dotti et al., 1988; Goslin and Banker, 1989; Deitch and
Banker, 1993). What induces this critical developmental transi-
tion? One possible explanation is that this phenotypic change is
initiated by the induction of new gene expression or by the
increased expression of certain key protein(s). The slow time
course with which inhibitors of RNA or protein synthesis block
the development of polarity argues against these possibilities. The
percentage of cells with axons increased normally in the presence
of CHX for at least 3 hr and in the presence of ACT D for at least
6 hr. This suggests that the full complement of proteins and
mRNA required for the development of polarity can be present
for several hours before polarity is actually established.
When axons of 1-d-old neurons are transected near the cell
body, the polarity of the cell is often altered (Goslin and Banker,
1990). A different neurite becomes the axon. When lesions are
made at greater distances, the lesioned axon retains its identity.
One hypothesis put forth to explain these effects is that the influx
of Ca21 at the lesion site and its spread to the cell body deter-
mined which process eventually became the axon (Mattson et al.,
1990). The present results show that polarity can be altered when
Figure 8. The effects of cycloheximide on neurite elongation. The set of phase contrast micrographs illustrates a cell just before treatment with 71 mM
cycloheximide (A) and 2 hr ( B), 3 hr ( C), 6 hr ( D), and 12 hr ( E) after treatment. Axonal growth continued normally for 3 hr after the addition of
cycloheximide. By 6 hr, the axon had stopped growing and had retracted slightly, and its growth cone had disappeared. Over the next 6 hr, the axon
became thinner and retracted still more. The minor processes also became thinner over time, but they did not retract. Scale bar, 20 mm.
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BFA treatment causes axons to retract. BFA treatment is unlikely
to induce the influx of Ca21.
Conclusion
One key to understanding axonal growth and the development of
polarity is the regulation of the trafficking of required materials.
Much of the research concerning axonal growth has focused on
the growth cone because it seems to be the primary site for the
assembly and disassembly of the cytoskeleton involved in process
outgrowth. The regulation of growth must also depend on the
supply of membranous elements. The data presented here show
that changes in the availability of Golgi-derived materials can also
affect the outgrowth of axons. Further work examining vesicular
trafficking during periods of selective growth of neurites should
provide insight into how cells coordinate the supply of membrane
material with the demands of growth.
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